| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 妇科类(元) | - | 290,644,912.63 | 282,579,184.96 |
| 抗肿瘤类(元) | - | 1,231,944,248.38 | 1,272,623,707.88 |
| 心脑血管类(元) | - | 283,169,754.93 | 313,118,425.44 |
| 医疗服务(元) | 230,776,300.00 | 458,063,738.09 | 456,786,557.27 |
| 医药工业板块(元) | 924,822,400.00 | - | - |
| 其他(元) | - | 544,288,658.05 | 404,179,213.26 |
| 营业成本(元) | |||
| 妇科类(元) | - | 115,558,830.35 | 103,755,680.07 |
| 抗肿瘤类(元) | - | 128,117,018.97 | 102,700,420.65 |
| 心脑血管类(元) | - | 84,865,608.85 | 79,465,719.03 |
| 医疗服务(元) | - | 348,935,183.75 | 367,775,136.88 |
| 医药工业板块(元) | - | - | - |
| 其他(元) | - | 178,064,595.43 | 137,840,298.13 |
| 毛利(元) | |||
| 妇科类(元) | - | 175,086,082.28 | 178,823,504.89 |
| 抗肿瘤类(元) | - | 1,103,827,229.41 | 1,169,923,287.23 |
| 心脑血管类(元) | - | 198,304,146.08 | 233,652,706.41 |
| 医疗服务(元) | - | 109,128,554.34 | 89,011,420.39 |
| 医药工业板块(元) | - | - | - |
| 其他(元) | - | 366,224,062.62 | 266,338,915.13 |
| 毛利率(%) | |||
| 妇科类(%) | - | 60.24 | 63.28 |
| 抗肿瘤类(%) | - | 89.60 | 91.93 |
| 心脑血管类(%) | - | 70.03 | 74.62 |
| 医疗服务(%) | - | 23.82 | 19.49 |
| 医药工业板块(%) | - | - | - |
| 其他(%) | - | 67.28 | 65.90 |
| 收入构成(%) | |||
| 妇科类(%) | - | 10.35 | 10.35 |
| 抗肿瘤类(%) | - | 43.87 | 46.63 |
| 心脑血管类(%) | - | 10.08 | 11.47 |
| 医疗服务(%) | 19.97 | 16.31 | 16.74 |
| 医药工业板块(%) | 80.03 | - | - |
| 其他(%) | - | 19.38 | 14.81 |
| 毛利构成(%) | |||
| 妇科类(%) | - | 8.97 | 9.23 |
| 抗肿瘤类(%) | - | 56.53 | 60.38 |
| 心脑血管类(%) | - | 10.16 | 12.06 |
| 医疗服务(%) | - | 5.59 | 4.59 |
| 医药工业板块(%) | - | - | - |
| 其他(%) | - | 18.76 | 13.74 |